INTOX Home Page

International Agency for Research on Cancer (IARC) - Summaries & Evaluations


VOL.: 10 (1976) (p. 217)

5. Summary of Data Reported and Evaluation

5.1 Animal carcinogenicity data

No adequate tests to assess the carcinogenicity of reserpine in experimental animals were available to the Working Group.

5.2 Human carcinogenicity data

Results from a number of epidemiological studies are not consistent in indicating an increased risk of cancer in patients exposed to Rauwolfia derivatives, and any conclusion about the existence of a risk should await further evidence.

Subsequent evaluations: Vol. 24 (1980); Suppl. 7 (1987)

Last updated: 22 March 1998

See Also:
        Reserpine (IARC Summary & Evaluation, Supplement 7, 1987)
        Reserpine (IARC Summary & Evaluation, Volume 24, 1980)
        Reserpine (PIM 467)